5 Stocks Insiders are Buying Now
Block, Inc. (NYSE:SQ) ranks 5th in our list of the stocks insiders are buying now. Both Roelof, a director at Block, Inc.
Janux Therapeutics Inc. (JANX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ovata Capital Management James Chen | 40,000 | $1,506,000 | 0.78% | |
| 2. | Bailard Inc Thomas Bailard | 7,400 | $278,610 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.87 | 849,854 | Large Shareholder, Officer | 849,854 | 2023-11-13 | Filing | |
| $5.87 | 849,854 | Large Shareholder, Director | 849,854 | 2023-11-13 | Filing | |
| $5.87 | 849,854 | Large Shareholder | 849,854 | 2023-11-13 | Filing | |
| $12.46 | 495,008 | Large Shareholder, Director | 8,117,246 | 2023-07-19 | Filing | |
| $17.00 | 58,823 | Large Shareholder | 3,749,250 | 2021-06-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.30 | 3,700 | Director | 231,098 | 2021-12-29 | Filing | |
| $20.30 | 36,700 | Director | 2,258,566 | 2021-12-29 | Filing | |
| $20.30 | 3,700 | Director | 231,098 | 2021-12-29 | Filing | |
| $20.30 | 36,700 | Director | 2,258,566 | 2021-12-29 | Filing | |
| $19.00 | 11,100 | Director | 234,798 | 2021-12-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,671,213 | $50,122,115 | 0% | |
| 2. | 1,931,477 | $20,744,359 | 0.01% | |
| 3. | 1,762,101 | $18,907,344 | 0% | |
| 4. | 979,483 | $10,509,853 | 0% | |
| 5. | 408,190 | $4,380,356 | 0% |
News See All
10 Healthcare Stocks with Insider Buying
Investors were processing inflation report on August 10 to find clues on the Federal Reserve’s possible moves. CPI’s growth in July was identical to that of June’s.
15 Pharmaceutical Stocks to Buy According to Peter Kolchinsky's RA Capital
In this piece, we will take a look at the top 15 pharmaceutical stocks to buy according to Peter Kolchinsky's RA Capital.
15 Biotech Stocks to Buy Now According to Srini Akkaraju and Michael Dybbs' Samsara BioCapital
In this article, we will discuss 15 biotech stocks to buy now according to Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
Billionaire Hedge Funds
